These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 530124)

  • 21. [Piazolina and arilid in experimental tuberculosis of guinea pigs].
    Janowiec M
    Gruzlica; 1967 Feb; 35(2):149-52. PubMed ID: 6045024
    [No Abstract]   [Full Text] [Related]  

  • 22. [Chemotherapeutic properties of the alkaloid tetrandrin in experimental tuberculosis].
    Vichkanova SA; Makarova LV; Solov'eva LF
    Farmakol Toksikol; 1973; 36(1):74-8. PubMed ID: 4734361
    [No Abstract]   [Full Text] [Related]  

  • 23. Subcutaneous nanoparticle-based antitubercular chemotherapy in an experimental model.
    Pandey R; Khuller GK
    J Antimicrob Chemother; 2004 Jul; 54(1):266-8. PubMed ID: 15128731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of anabolic steroid hormones in the treatment of experimental tuberculosis].
    Kashenov T
    Sov Zdravookhr Kirg; 1972; 3():13-5. PubMed ID: 4666412
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapeutic efficiency of ethionamide and prothionamide].
    Kozulitsyna TI; Zemskova ZS
    Probl Tuberk; 1969; 47(8):66-9. PubMed ID: 5375685
    [No Abstract]   [Full Text] [Related]  

  • 26. Anti tubercular activity of garlic oil.
    Jain RC
    Indian J Pathol Microbiol; 1998 Jan; 41(1):131. PubMed ID: 9581089
    [No Abstract]   [Full Text] [Related]  

  • 27. [Morphological aspects of the infection and re-infection with M.t. (Mycobacterium tuberculosis) resistant to chemo-antibiotics].
    Stroniello G
    Arch Monaldi; 1972; 27(3):284-9. PubMed ID: 4219269
    [No Abstract]   [Full Text] [Related]  

  • 28. Nanotechnology based drug delivery system(s) for the management of tuberculosis.
    Pandey R; Khuller GK
    Indian J Exp Biol; 2006 May; 44(5):357-66. PubMed ID: 16708887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Experimental therapy with so-called "minor" tuberculostatics].
    Freerksen E
    Wien Med Wochenschr; 1966 Oct; 116(42):874-7. PubMed ID: 6005730
    [No Abstract]   [Full Text] [Related]  

  • 30. Feasibility studies on division of fixed dose combinations of anti-tubercular drugs: an improvement in the tuberculosis therapy.
    Ashokraj Y; Kohli G; Kaur KJ; Bhade SR; Varma MV; Sarkar M; Kapoor N; Singh I; Kandavilli S; Panchagnula R
    J Clin Pharm Ther; 2006 Apr; 31(2):201-3. PubMed ID: 16635057
    [No Abstract]   [Full Text] [Related]  

  • 31. Azole antifungals as novel chemotherapeutic agents against murine tuberculosis.
    Ahmad Z; Sharma S; Khuller GK
    FEMS Microbiol Lett; 2006 Aug; 261(2):181-6. PubMed ID: 16907718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Changes in the lipid metabolic indices as affected by tuberculosis and the action of antitubercular preparations in an experiment].
    Solov'eva TN; Malakhova MIa
    Probl Tuberk; 1984 Mar; (3):56-60. PubMed ID: 6718347
    [No Abstract]   [Full Text] [Related]  

  • 33. [Overview on preclinical research on tuberculosis chemotherapy in the past 100 years. (2) Experimental studies following clinical tests].
    Kanei T; Kondo E
    Kekkaku; 1983 Apr; 58(4):235-45. PubMed ID: 6632485
    [No Abstract]   [Full Text] [Related]  

  • 34. [The combined effect of histones and antibiotics. Treatment of experimental tuberculosis in guinea pigs and white mice with tubazid combined with histones].
    Perel'man AE; Ashmarin IP; Gaber IE; Vishnevskiĭ BI; Goriukhina OA
    Antibiotiki; 1974 Apr; 19(4):351-4. PubMed ID: 4463874
    [No Abstract]   [Full Text] [Related]  

  • 35. [Glucose-6-phosphatase activity in tuberculosis-infected animals during long-term use of bacteriostatic agents and group B vitamins].
    Romaniuk SL
    Probl Tuberk; 1971; 49(1):76-9. PubMed ID: 4325146
    [No Abstract]   [Full Text] [Related]  

  • 36. [Several current problems in chemotherapy of tuberculosis].
    Moisescu V
    Ftiziologia; 1973; 22(3):225-37. PubMed ID: 4197127
    [No Abstract]   [Full Text] [Related]  

  • 37. [Various indicators of the immunological response of the body after inclusion of pathogenetic agents in the chemotherapy of tuberculosis].
    Sibirnaia RI; Beliakova OI
    Probl Tuberk; 1984 Sep; (9):28-30. PubMed ID: 6334296
    [No Abstract]   [Full Text] [Related]  

  • 38. Tuberculostatic activity of N-morpholino-4'-méthylamide pyrazincarbonic acid on experimental tuberculosis in mice.
    Verbist L
    Acta Tuberc Pneumol Belg; 1966; 57(3):211-7. PubMed ID: 5985965
    [No Abstract]   [Full Text] [Related]  

  • 39. [An experimental study of the chemotherapeutic efficacy of flurenizid, a new antitubercular pharmaceutical].
    Khomenko AG; Golyshevskaia VI; Maslova LI; Kalmykova GN; Uvarova OA
    Probl Tuberk; 1990; (6):3-7. PubMed ID: 2217100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doctors report breakthrough antibiotic treatment for TB.
    AIDS Read; 2007 Nov; 17(11):528, 534. PubMed ID: 18167636
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.